DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
Aktueller Standort:
> This Story

Forward Printable StoryPrint Comment




U.S. Healthcare Homepage

Patent issued for a new type of transparent radiation shielding for the medical and nuclear industries

AMIA calls on ONC to ‘flip the paradigm’ of data access with Cures Act implementation

First states to expand Medicaid saw larger screening rate increases

MemorialCare Orange Coast Medical Center earns ACR Accreditation for comprehensive imaging modalities

Varian announces incremental gross impact of new tariffs

Radiology Partners expands national leadership position through partnership with Greensboro Radiology

Context-sensing technology from Holon Solutions to address interopoerability awarded U.S. patent

Georgia becomes 38th state with a breast density inform law

FDA seeks feedback on patient preferences that may impact regulatory decisions on medical devices

Invicro and iThera Medical announce a strategic partnership to enhance in vivo imaging capabilities

New report from Vizient assesses the challenges for hospitals in evaluating and adopting innovative medical devices

Press releases may be edited for formatting or style
IRVING, Texas--(BUSINESS WIRE)--Over the last six years, the U.S. Food and Drug Administration has approved a number of highly innovative medical devices that have revolutionized cardiovascular care. These novel devices have provided advanced treatment options, improved quality of life and extended longevity for patients. Unfortunately, reimbursement has often failed to keep up with many of increasingly expensive treatment options. In the report, “The cost of medical device innovation: can we keep pace?” released today, Vizient looks at how hospitals must develop a systematic process that enables the evaluation and adoption of emerging technology in a way that benefits patients and providers in a financially sustainable way.

“A critical question facing providers is when they should implement an innovative technology. Physicians often want to be early adopters and have access to the latest technology because their goal is to always provide the best care for patients. But many potentially innovative technologies are never widely adopted for various reasons,” said Joe Cummings, technology program director for Vizient and a contributor to the white paper. “To use a value-based evaluation paradigm, the hospital’s technology adoption committee must engage in a systematic review of the clinical literature to determine pertinent clinical outcomes and also conduct financial analyses to estimate the total cost of care.”

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED

Key findings from the report include:

An average 273.3 percent increase in price over the predicate medical device was found in a review of Vizient data for several recent innovative cardiovascular medical device introductions.
A review of select cardiovascular medical devices revealed considerable variability in the ratio of device cost to reimbursement. In fact, for some of the recent innovations, the device cost alone consumed a very high proportion of the overall reimbursement for the procedure, leaving minimal coverage for other expenses such as supplies, room costs and other miscellaneous resources required for the procedure.
Hospitals, working collaboratively through multidisciplinary committees, must use a systematic, open and objective process focused on innovation assessments to determine which technologies provide better (optimal) patient care with improved value.
Suppliers initially, then technology advocates, must provide better clinical data during the launch and early-adopter phases of a medical device introduction. The data must clearly demonstrate better outcomes to support informed decision-making by physicians and hospitals.
  Pages: 1 - 2 >>

U.S. Healthcare Homepage

You Must Be Logged In To Post A Comment

Erhöhen Sie Ihren Bekanntheitsgrad
Auktionen + Privatverkäufe
Den besten Preis erzielen
Geräte/Geräteteile kaufen
Den günstigsten Preis finden
Daily News
Die neuesten Nachrichten lesen
Alle DOTmed Benutzer durchsuchen
Ethik auf DOTmed
Unseren Ethik-Standard anzeigen
Gold-Parts Verkäufer-Programm
PH-Anfragen erhalten
Gold Service Dealer-Programm
Anfragen empfangen
Alle Gesundheitsdienstleister-Tools anzeigen
Einen Job suchen
Parts Hunter +EasyPay
Angebote für Geräteteile erhalten
Kürzlich zertifiziert
Kürzlich zertifizierte Benutzer anzeigen
Kürzlich bewertet
Kürzlich zertifizierte Benutzer anzeigen
Rental Central
Geräte billiger mieten
Geräte/Geräteteile verkaufen
Das meiste Geld erhalten
Service-Techniker Forum
Hilfe und Beratung finden
Einfache Angebots-Anfrage
Angebote für Geräte erhalten
Virtuelle Messe
Service für Geräte finden
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2019, Inc.